CoChat

Infective Endocarditis Due to Penicillin-Resistant Viridans Group Streptococci

Knoll, B., Tleyjeh, I. M., Steckelberg, J. M., Wilson, W. R., Baddour, L. M. · 2007 · Clinical Infectious Diseases

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The emergence of viridans group streptococci that are relatively or fully resistant to penicillin is increasingly being recognized worldwide, but only a scant number of penicillin-resistant isolates have been described as a cause of infective endocarditis. Because of the paucity of data, it has been difficult to define optimal treatment regimens for this syndrome. Thus, recommendations for therapy have largely been made on the basis of consensus opinion. METHODS: We retrospectively identified a cohort of patients with infective endocarditis due to penicillin-resistant viridans group streptococci who were seen at the Mayo Clinic (Rochester, MN) between January 1967 and April 2006. Demographic characteristics, clinical features, treatment regimens, and outcomes were analyzed. Mean values are shown with standard deviations. RESULTS: Twenty-nine patients were identified over the 38.5-year study period. Nineteen patients with native valve endocarditis were cured; 9 of these 19 patients received a 2.3+/-0.4-week antibiotic regimen consisting of penicillin and an aminoglycoside, and 8 of these 19 patients received treatment courses of 5.1+/-1.4 weeks' duration that consisted of either a bimodal combination regimen with a penicillin or ceftriaxone and an aminoglycoside or ceftriaxone monotherapy. Nine of 10 patients with prosthetic valve infection were cured with 4.1+/-0.6-week regimens that consisted of either a combination regimen or monotherapy with vancomycin or ceftriaxone. Mean duration of follow-up after hospital discharge was 9.1 years. CONCLUSIONS: Outcomes of this relatively large population of patients with endocarditis with a prolonged duration of follow-up indicate that the application of current treatment guidelines should be successful in most patients.

Overview

Integrity signals

Registry

Crossref · 10.1086/518174

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 29 references

Cited by

See all 70

Metadata

Authors
Knoll, B., Tleyjeh, I. M., Steckelberg, J. M., Wilson, W. R., & Baddour, L. M.
Affiliations
  • Mayo Clinic (US)
  • King Fahd Medical City (SA)
Corresponding author
Knoll, B.
Venue
Clinical Infectious Diseases
Published
2007-06-15
Volume
44
Issue
12
Pages
1585-1592
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2155164226
Cited by
70
References
29
Citations by year
2026: 1 · 2025: 4 · 2024: 6 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 5 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 5 · 2014: 1 · 2013: 4 · 2012: 5
FWCI
3.90
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Funders
Mayo Clinic
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords
infective endocarditis, Streptococcus viridans, penicillin resistance, antibiotic regimens, ceftriaxone, vancomycin, aminoglycosides, native valve endocarditis, prosthetic valve endocarditis, treatment outcomes
MeSH terms
Adult, Aged, Cross Infection, Endocarditis, Bacterial, Female, Heart Valve Prosthesis, Hospitals, Teaching, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Penicillin Resistance, Retrospective Studies, Streptococcal Infections, Cohort Studies, Treatment Outcome, Practice Guidelines as Topic, Community-Acquired Infections, Disease-Free Survival, Viridans Streptococci

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Infective Endocarditis Due to Penicillin-Resistant Viridans Group Streptococci. https://app.cochat.ai/papers/10.1086/518174
The paper
Knoll, B., Tleyjeh, I. M., Steckelberg, J. M., Wilson, W. R., & Baddour, L. M. (2007). Infective Endocarditis Due to Penicillin-Resistant Viridans Group Streptococci. Clinical Infectious Diseases. https://doi.org/10.1086/518174

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.